Peter Smith

4.8k total citations · 1 hit paper
61 papers, 2.2k citations indexed

About

Peter Smith is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Smith has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Smith's work include Pulmonary Hypertension Research and Treatments (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers) and Cardiac and Coronary Surgery Techniques (11 papers). Peter Smith is often cited by papers focused on Pulmonary Hypertension Research and Treatments (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers) and Cardiac and Coronary Surgery Techniques (11 papers). Peter Smith collaborates with scholars based in United Kingdom, United States and France. Peter Smith's co-authors include Kenneth M. Taylor, Chandana Ratnatunga, George Asimakopoulos, Thomas E. Hall, Ian A. Johnston, Steven D. Nathan, Aaron B. Waxman, Victor F. Tapson, C. Q. Deng and Stanton Newman and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Peter Smith

57 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

2021 336 citations Aaron B. Waxman, Ricardo Restrepo‐Jaramillo et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Smith United Kingdom	23	955	717	679	216	206	61	2.2k
Junya Aoki Japan	28	1.5k 1.6×	878 1.2×	217 0.3×	90 0.4×	100 0.5×	182	4.3k
Richard L. Applegate United States	25	228 0.2×	374 0.5×	612 0.9×	64 0.3×	134 0.7×	114	1.9k
Sachie Suga Japan	23	866 0.9×	2.8k 3.9×	400 0.6×	32 0.1×	198 1.0×	41	3.9k
Minato Yokoyama Japan	26	737 0.8×	107 0.1×	909 1.3×	245 1.1×	71 0.3×	160	2.5k
Oded Zmora Israel	40	549 0.6×	530 0.7×	3.0k 4.4×	79 0.4×	90 0.4×	135	4.5k
A. P. Fishman United States	9	2.7k 2.8×	1.8k 2.5×	380 0.6×	44 0.2×	77 0.4×	12	3.1k
Marco Mura Canada	27	1.5k 1.5×	151 0.2×	542 0.8×	28 0.1×	106 0.5×	99	2.8k
Hiroshi Niwa Japan	25	803 0.8×	64 0.1×	473 0.7×	45 0.2×	44 0.2×	175	2.5k
Kenji Andò Japan	30	926 1.0×	2.5k 3.5×	2.1k 3.1×	65 0.3×	156 0.8×	316	3.9k
Geoffrey M. Collins United States	20	304 0.3×	92 0.1×	1.1k 1.6×	23 0.1×	91 0.4×	82	1.9k

Countries citing papers authored by Peter Smith

Since Specialization

Citations

This map shows the geographic impact of Peter Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Smith more than expected).

Fields of papers citing papers by Peter Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Smith. The network helps show where Peter Smith may publish in the future.

Co-authorship network of co-authors of Peter Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Smith. A scholar is included among the top collaborators of Peter Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Smith. Peter Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sahay, Sandeep, Harold I. Palevsky, Karim El‐Kersh, et al.. (2025). BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension. Respiratory Medicine. 248. 108318–108318.

Nathan, Steven D., Jürgen Behr, Vincent Cottin, et al.. (2024). Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis. SHILAP Revista de lepidopterología. 3(2). 100124–100124. 3 indexed citations

Cottin, Vincent, et al.. (2024). Study Design and Rationale for the TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis. A3760–A3760. 2 indexed citations

Gilbert‐Ouimet, Mahée, et al.. (2024). Incorporating sex and gender considerations in research on psychosocial work exposures and cardiovascular diseases: A systematic review of 55 prospective studies. Neuroscience & Biobehavioral Reviews. 167. 105916–105916. 2 indexed citations

Nathan, Steven D., Shilpa Johri, Christopher S. King, et al.. (2023). Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality. Thorax. 79(4). 301–306. 12 indexed citations

Nathan, Steven D., Jürgen Behr, Vincent Cottin, et al.. (2022). Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis. BMJ Open Respiratory Research. 9(1). e001310–e001310. 40 indexed citations

Nathan, Steven D., Victor F. Tapson, Jean Elwing, et al.. (2021). Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial. American Journal of Respiratory and Critical Care Medicine. 205(2). 198–207. 44 indexed citations

Waxman, Aaron B., Ricardo Restrepo‐Jaramillo, Thenappan Thenappan, et al.. (2021). Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. New England Journal of Medicine. 384(4). 325–334. 336 indexed citations breakdown →

Giustino, Gennaro, Jessica Overbey, Gorav Ailawadi, et al.. (2019). SEX-BASED DIFFERENCES IN OUTCOMES AFTER MITRAL VALVE SURGERY FOR SEVERE ISCHEMIC MITRAL REGURGITATION: FROM THE CARDIOTHORACIC SURGICAL TRIALS NETWORK. Journal of the American College of Cardiology. 73(9). 1951–1951. 13 indexed citations

10.

Smith, Peter, et al.. (2019). A phase 1, single-center, open-label, dose-rising clinical trial to evaluate the pharmacokinetics, safety and tolerability of treprostinil inhalation powder (TreT) in healthy normal volunteers. PA4749–PA4749. 4 indexed citations

11.

Day, Jonathan, et al.. (2003). Castleman’s disease associated with myasthenia gravis. The Annals of Thoracic Surgery. 75(5). 1648–1650. 28 indexed citations

12.

Lawrence, David, et al.. (2002). An unusual cause of mixed mitral valve disease. Heart. 88(6). 560–560. 1 indexed citations

13.

Asimakopoulos, George, et al.. (1999). Prevalence of acute respiratory distress syndrome after cardiac surgery. Journal of Thoracic and Cardiovascular Surgery. 117(3). 620–621. 32 indexed citations

14.

Habib, Nagy, et al.. (1996). The use of hypothermia and circulatory arrest to control intraoperative bleeding from the inferior vena cava. Surgery Today. 26(3). 217–218. 6 indexed citations

15.

Smith, Peter, et al.. (1995). Ovarian characteristics in Inverdale ewes heterozygous (I+) and homozygous (II) for the Inverdale gene (FecX). Proceedings of the New Zealand Society of Animal Production. 55. 301–303. 2 indexed citations

16.

Gosney, J R, et al.. (1994). Pretransplant clinicopathological correlation in end-stage primary pulmonary hypertension. European Respiratory Journal. 7(4). 672–678. 6 indexed citations

17.

Blauth, Christopher, et al.. (1990). Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 99(1). 61–69. 93 indexed citations

18.

Jagoe, J. R., et al.. (1989). Quantification of retinal damage during cardiopulmonary bypass. International Conference on Image Processing. 319–323. 3 indexed citations

19.

Gosney, John R., D Heath, Peter Smith, Peter L. Harris, & Magdi H. Yacoub. (1989). Pulmonary endocrine cells in pulmonary arterial disease.. PubMed. 113(4). 337–41. 30 indexed citations

20.

Qureshi, Shakeel, Murtada A. Halim, Ravi Pillai, Peter Smith, & Magdi H. Yacoub. (1985). Endarterectomy of the left coronary system. Journal of Thoracic and Cardiovascular Surgery. 89(6). 852–859. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact